小叶 刘
As the first professional injection producer in China,Shanghai Haipu Pharmaceutical factory was founded in 1925 and renamed as Shanghai Xudong Haipu Pharmaceutical Co.,Ltd after jointed with Taiwan Tungyang International Co.,Ltd in 1993.The company has developed for more than 90 years so far, and has accumulated rich experience in production and brand awareness.
Shanghai Xudonghelp
BD经理建昆 刘
康为同创集团成立于2006年,位于北京市密云区经济开发区内,主要从事特种传动设备、电机电气、高端智能装备、智能传感器、智能芯片等的研发、生产、制造,是集产、学、研于一体的大型智能生产制造企业。产品广泛应用于轨道交通、商用航空器、基础工业、智能城市等诸多领域。
企业从成立之日起始终秉承“用户第一、质量第一、信誉第一、智能第一、双赢第一”的原则。已成功申请为国家高新技术企业,并取得国际铁路行业IRIS认证证书。集团公司经多年发展已初步建立起以智能设计为先导的智能化生产制造企业。为适应智能事业的需要,集团公司不断为客户提高更优质的服务。
企业从成立之日起始终秉承“用户第一、质量第一、信誉第一、智能第一、双赢第一”的原则。已成功申请为国家高新技术企业,并取得国际铁路行业IRIS认证证书。集团公司经多年发展已初步建立起以智能设计为先导的智能化生产制造企业。为适应智能事业的需要,集团公司不断为客户提高更优质的服务。
康为同创集团有限公司
技术商务部主管薇 刘
Luye Pharma Group, a member of Luye Life Sciences Group, is an international pharmaceutical company with a focus on targeting central nervous system (CNS), oncology and other therapeutic areas. Global R&D, global manufacturing, and the global sale of innovative medications are the company’s three main strategic priorities.
Luye Pharma Group
bd 总监杨 刚
Chengdu Jian River Pharmaceutical Co., Ltd. was established in 2019 with a registered capital of 20 million yuan. The establishment of jianRiver serves Sichuan Development (Holdings) Co., Ltd. and the people's Government of Pengzhou City to set up a "Pengzhou Fund". For Tianfu traditional Chinese Medicine City in the global recruitment and incubation of pharmaceutical projects, through docking funds to provide professional management and services to provide support for the growth of the project. As the main body of the construction and operation of the innovation incubator in Pengzhou Tianfu traditional Chinese Medicine City, relying on rich project channel resources and professional service team, it is committed to helping excellent modern Chinese medicine research and development enterprises, new drug research and development enterprises, cutting-edge biotechnology companies, medical device companies and large health industry related enterprises to accurately land in Pengzhou, through the whole industry chain services such as professional incubation acceleration, achievement transformation and financial investment. Promote the rapid development of innovative start-up enterprises. Adhering to the concept that "high-quality projects are the foundation of industrial development, and first-class talents are the core force of project growth", Jian River will gather high-quality projects to jointly build a high-quality medicine and large-scale health project incubation base in Pengzhou. Help more outstanding top entrepreneurial talents to realize their entrepreneurial ideals.
Chengdu Jian River Pharmaceutical Co., Ltd.
商务总监玉忠 化
license in innovative medicine and 505(b)(2),R&D generic drugs
Yatai institute of innovative medicine
商务VPNicky 吕
Founded in 2005, Baiyu is dedicated to R&D, manufacturing and marketing high-quality pharmaceutical products and APIs to all patients. As an innovation-based pharmaceutical company, we are specializing in chemical/botanical/biological medicinal products, especially ginkgo pharmaceutical products. And in 2020, aiming to protect everyone’s healthcare, Baiyu has built own subsidiary to produce high quality of Personal Protective Equipment to worldwide market.
With more than 1,300 employees and 8 wholly owned subsidiaries, Baiyu has a rich pipeline of products launched for neuropsychiatric, cardio-cerebrovascular, anti-tumor, respiratory, digestive, anti-infective areas along with many products under development. And Ginkgolide injection is the first innovative botanical injectable approved since the implementation of Drug Registration Regulation (2007), of which the active ingredient contents reach up to 99%.
Currently, several production lines have obtained GMP certificates, and new factories meeting EU&US GMP requirements with fully automatic and intelligent operations have been built to accelerate Baiyu’s globalization process.
With more than 1,300 employees and 8 wholly owned subsidiaries, Baiyu has a rich pipeline of products launched for neuropsychiatric, cardio-cerebrovascular, anti-tumor, respiratory, digestive, anti-infective areas along with many products under development. And Ginkgolide injection is the first innovative botanical injectable approved since the implementation of Drug Registration Regulation (2007), of which the active ingredient contents reach up to 99%.
Currently, several production lines have obtained GMP certificates, and new factories meeting EU&US GMP requirements with fully automatic and intelligent operations have been built to accelerate Baiyu’s globalization process.